Ephicacy News and Activities

Ephicacy is owned by Great Point Partners.

They are in:

• Fund50%
• Biotechnology50%

View the org chart displaying its 7 main executives

Most searched biographies at Ephicacy

• Tara Gladwell, Chief Executive Officer
• Venkat Rajagopal, Vice President, Operations
• Sukhvinder Singh, Chief Financial Officer

Create your alert
to follow the executive moves at Ephicacy.

Great Point Partners has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).
• Scribe Therapeutics has filed its IPO. Its stock ticker will be SCTX. (posted on July 7 2026).
• ClearOne Communications has announced the acquisition of Cortigent  (posted on July 6 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Ephicacy

• News & Events | Ephicacy
• Ephicacy Consulting Group Completes Acquisition of Advance Research Associates

Social media about Ephicacy

• Ephicacy on Wikipedia, Google News & Yahoo Finance
• Ephicacy on LinkedIn, X (Twitter) & YouTube